Cancer Letters 2015-09-28

Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer

Tomohiro Yonezawa, Kuan-Hui (Ethan) Chen, Mrinal K. Ghosh, Lorena Rivera, Riva Dill, Lisa Ma, Pedro A. Villa, Mitsumori Kawaminami, Ameae M. Walker

Index: Cancer Lett. 366 , 84-92, (2015)

Full Text: HTML

Abstract

• The work establishes a crucial role for the long prolactin receptor in metastatic spread of breast cancer. • The spice-modulating agent has potential as a well-tolerated cancer therapeutic. • The principle of isoform-specific knockdown can be applied to multiple targets in breast and other cancers.

Related Compounds

  • beta-Estradiol
  • Formaldehyde
  • Progesterone
  • Prolactin, Human...
  • Ethylenediaminetet...

Related Articles:

Inducible, tightly regulated and growth condition-independent transcription factor in Saccharomyces cerevisiae.

2014-01-01

[Nucleic Acids Res. 42(17) , e130, (2014)]

A precisely substituted benzopyran targets androgen refractory prostate cancer cells through selective modulation of estrogen receptors.

2015-03-15

[Toxicol. Appl. Pharmacol. 283(3) , 187-97, (2015)]

Alpha-fetoprotein, identified as a novel marker for the antioxidant effect of placental extract, exhibits synergistic antioxidant activity in the presence of estradiol.

2014-01-01

[PLoS ONE 9(6) , e99421, (2014)]

Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86.

2014-01-01

[BMC Cancer 14 , 853, (2014)]

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.

2015-04-01

[Cancer Res. 75(7) , 1457-69, (2015)]

More Articles...